Chemical Component Summary

Name7-(3,5-DITERT-BUTYLPHENYL)-3-METHYLOCTA-2,4,6-TRIENOIC ACID
Identifiers(2E,4E,6E)-7-(3,5-ditert-butylphenyl)-3-methyl-octa-2,4,6-trienoic acid
FormulaC23 H32 O2
Molecular Weight340.499
TypeNON-POLYMER
Isomeric SMILESC\C(=C/C(=O)O)\C=C\C=C(/C)\c1cc(cc(c1)C(C)(C)C)C(C)(C)C
InChIInChI=1S/C23H32O2/c1-16(12-21(24)25)10-9-11-17(2)18-13-19(22(3,4)5)15-20(14-18)23(6,7)8/h9-15H,1-8H3,(H,24,25)/b10-9+,16-12+,17-11+
InChIKeyJMPZTWDLOGTBPM-OUQSKUGOSA-N

Chemical Details

Formal Charge0
Atom Count57
Chiral Atom Count0
Bond Count57
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB05785 
NameLGD-1550
Groups investigational
DescriptionLGD-1550 is an orally-active synthetic aromatic retinoic acid agent with potential antineoplastic and chemopreventive activities.
SynonymsLGD-1550
IndicationInvestigated for use/treatment in cancer/tumors (unspecified).
Categories
  • Alkenes
  • Biological Factors
  • Carotenoids
  • Cyclohexanes
  • Cyclohexenes
CAS number178600-20-9

Drug Targets

NameTarget SequencePharmacological ActionActions
Retinoic acid receptor alphaMASNSSSCPTPGGGHLNGYPVPPYAFFFPPMLGGLSPPGALTTLQHQLPV...unknown
Retinoic acid receptor betaMTTSGHACPVPAVNGHMTHYPATPYPLLFPPVIGGLSLPPLHGLHGHPPP...unknown
Retinoic acid receptor gammaMATNKERLFAAGALGPGSGYPGAGFPFAFPGALRGSPPFEMLSPSFRGLG...unknown
Transcription factor AP-1MTAKMETTFYDDALNASFLPSESGPYGYSNPKILKQSMTLNLADPVGSLK...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL89241
PubChem 5287705
ChEMBL CHEMBL89241